The page is the record's research on the issuer — no analyst, no rating, no view. # Arbutus Biopharma Corp (NASDAQ: ABUS) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Arbutus Biopharma Corp is listed on NASDAQ under the ticker ABUS, with ISIN US03879J1007. The record holds no LEI for the issuer, as no GLEIF record carries the exact legal name in jurisdiction US-A1. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is British Columbia, Canada. Its segment is not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 48 filings across 31 filing days in the window from 2025-11-08 to 2026-11-08. Filings by type are: directors' dealings 13, regulatory filing 11, corporate news 8, results 8, takeover 4, AGM/EGM 2, and director change 2. The median gap between filing days is 9.0 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. The latest filing is a regulatory filing dated 2026-10-27, 12 days before the record date. Median latency is 5.0 days for NASDAQ and 4.0 days for the sector, and median filings in the window are 52 for NASDAQ and 63.0 for the sector. ## Auditor The auditor of record is Ernst & Young LLP, located in Philadelphia, Pennsylvania. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record seals the issuer for the years 2021 through 2026. The market's vintage is sealed, with earliest sealed date 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001447028.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ABUS (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1447028/000144702826000017/abus-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ABUS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ABUS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp